MAPS
Summary:
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
Location:
San Jose, California, USA
People:
Rick Doblin (Founder and Executive Director)
Jonathan Lubecky (Veterans & Governmental Affairs Liaison)
Michael Mullette (Chief Operating Officer)
Jobs:
Justice, Equity, Diversity, and Inclusion (“JEDI”) Officer
Events:
Psychedelic Science 2023
Clinical Trials:
- Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma
- MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function
- Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)
- Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada)
- A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders
- Evaluation of MDMA on Startle Response
- Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
- MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD
- Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD
- Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults
- MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD
- A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)
- MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness
- A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD
- Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder
- Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial
- Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD
- Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers
- Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD
- A Multi-site Expanded Access Program for MDMA-assisted Psychotherapy for Patients With Treatment-resistant PTSD
- Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder
- Randomized, Double-blind, Active Placebo-Controlled Pilot Study of MDMA-assisted Psychotherapy in People With Chronic PTSD
- Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - Israel
- MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder
- Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification
- Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety
- Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study
- A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD
- Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD
- Food Effects on Bioavailability of MDMA in Healthy Volunteers
- A Treatment Development Study of MDMA-Assisted Psychotherapy for PTSD
- Social Anxiety MDMA-Assisted Therapy Investigation
- Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans
- Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
- Long-Term Safety and Effectiveness of Manualized MDMA-Assisted Therapy for the Treatment of Posttraumatic Stress Disorder
- Stanford Regulating Circuits of the Brain Study - MDMA
- Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy
- Correlates of Anxiety Associated With a Life-threatening Illness